AT..CHDE....FRGB....LI....SE........................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0776335A119970604EP95930868.01995081819970313enenen1994029259519940818US1994029259619940818US1994029259719940818US1997060419972319970604199723

A01K 67/ 027 A I

A61K 48/ 00 A I

C07K 7/ 64 A I

C07K 14/ 715 A I

C07K 14/ 725 A I

C07K 19/ 00 A I

C12N 5/ 10 A I

C12N 15/ 09 A I

C12N 15/ 63 A I

C12P 17/ 18 A I

enREGULATABLE ELIMINATION OF GENE EXPRESSION, GENE PRODUCT FUNCTION AND ENGINEERED HOST CELLSfrELIMINATION MODULABLE D'EXPRESSION GENIQUE, DE FONCTION DE PRODUIT GENIQUE, ET DE CELLULES HOTES OBTENUES PAR GENIE GENETIQUEdeREGULIERBARE ELIMINATION DER GENEXPRESSION, GENPRODUKTFUNKTION UND GENTECHNOLOGISCH HERGESTELLTE WIRTSZELLENARIAD GENE THERAPEUTICS, INC.26 Landsdowne StreetCambridge, MA 02139USBRUGGE, Joan, S.50 Sarah WayConcord, MA 01742USCRABTREE, Gerald, R.7 Durham RoadWoodside, CA 94062USMarchant, James Ian, et alElkington and Fife, Prospect House, 8 Pembroke RoadSevenoaks, Kent TN13 1XRGBATCHDEFRGBLISEUS199501059119950818enWO199600611119960229199610